Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter
- 31 December 2003
- journal article
- editorial
- Published by Elsevier in Experimental Neurology
- Vol. 184 (2) , 561-564
- https://doi.org/10.1016/j.expneurol.2003.08.004
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeysExperimental Neurology, 2003
- Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's diseaseJournal of Neurochemistry, 2002
- The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh‐TNF‐α, IL‐1β and IFN‐γJournal of Neurochemistry, 2002
- Engineered modeling and the secrets of Parkinson's diseaseTrends in Neurosciences, 2001
- The Single Intranigral Injection of LPS as a New Model for Studying the Selective Effects of Inflammatory Reactions on Dopaminergic SystemNeurobiology of Disease, 2000
- ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASEAnnual Review of Neuroscience, 1999
- Histochemical detection of apoptosis in Parkinson's diseaseJournal of the Neurological Sciences, 1996
- Glia-dependent neurotoxicity and neuroprotection in mesencephalic culturesBrain Research, 1995
- Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's diseaseNeuroscience Letters, 1994
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983